New hope for heart inflammation sufferers: experimental drug VTX2735 enters Mid-Stage trial

NCT ID NCT06836232

Recruiting now Disease control Sponsor: Zomagen Biosciences Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests an experimental drug called VTX2735 in 50 adults with recurrent pericarditis, a condition where the heart's lining becomes inflamed and painful. The goal is to see if the drug is safe and can reduce pain and inflammation. Participants receive different doses over several weeks, and researchers monitor side effects and symptom changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

idiopathic recurrent pericarditis pericarditis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RECURRENT PERICARDITIS

Contacts and locations

Locations

Local Site #840001
RECRUITING

Houston, Texas, 77034, United States
Local Site #840002
WITHDRAWN

Park Ridge, Illinois, 60068, United States
Local Site #840004
RECRUITING

Richmond, Virginia, 23219, United States
Local Site #840005
RECRUITING

Rochester, Minnesota, 55905, United States
Local Site #840008
RECRUITING

Chicago, Illinois, 60611, United States
Local Site #840010
RECRUITING

Boston, Massachusetts, 02114, United States
Local Site #840011
WITHDRAWN

Owensboro, Kentucky, 42303, United States
Local Site #840012
WITHDRAWN

Tucson, Arizona, 85718, United States
Local Site #840013
RECRUITING

Salt Lake City, Utah, 84132, United States
Local Site #840014
RECRUITING

Orange, California, 92868, United States
Local Site #840016
RECRUITING

Saint Augustine, Florida, 32086, United States
Local Site #840017
RECRUITING

Cleveland, Ohio, 44195, United States
Local Site #840018
RECRUITING

Charlottesville, Virginia, 22908, United States
Local Site #840019
RECRUITING

Houston, Texas, 77030, United States
Local Site #840020
RECRUITING

New York, New York, 10032, United States
Local Site #840021
RECRUITING

Seattle, Washington, 98105, United States
Local Site #840022
RECRUITING

Burlington, Vermont, 05401, United States
Local Site #840101
RECRUITING

Ottawa, Ontario, K1Y 4W7, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.